Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |
Phase III-ready rare disease drug for gastrointestinal and atopic diseases
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |